Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Director comp. Appointed director Appointed CFO Director departure Inv. presentation Quarterly results Consulting agrmnt
|
Alliqua BioMedical, Inc. (ADYX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/07/2019 |
4
| ABEL STAN E (Director) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 54,117 shares
@ $0 Granted 198 options to buy
@ $1.39, valued at
$275.2 Granted 27,940 options to buy
@ $3.06, valued at
$85.5k
|
|
05/07/2019 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 85,254 shares
@ $0 Granted 396 options to buy
@ $1.39, valued at
$550.4 Granted 55,879 options to buy
@ $3.06, valued at
$171k
|
|
05/07/2019 |
4
| Podlesak Dennis (Director) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 85,254 shares
@ $0 Granted 396 options to buy
@ $1.39, valued at
$550.4 Granted 55,879 options to buy
@ $3.06, valued at
$171k
|
|
05/07/2019 |
4
| MAMET JULIEN (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 240,454 shares
@ $0 Granted 33 options to buy
@ $1.39, valued at
$45.9 Granted 158,149 options to buy
@ $3.06, valued at
$483.9k
|
|
05/07/2019 |
4
| Manning Donald C. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 23,858 options to buy
@ $1.11, valued at
$26.5k
Granted 7,887 options to buy
@ $1.39, valued at
$11k
Granted 3,943 options to buy
@ $1.39, valued at
$5.5k
Granted 56,407 options to buy
@ $3.06, valued at
$172.6k
|
|
05/07/2019 |
4
| ORR RICK (CEO) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 142,090 shares
@ $0 Granted 661 options to buy
@ $1.39, valued at
$918.8 Granted 95,417 options to buy
@ $3.06, valued at
$292k
|
|
09/25/2017 |
4
| BARTON BRADFORD (COO) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Paid exercise price by delivering 67,536 shares
@ $0.42, valued at
$28.4k
|
|
09/25/2017 |
4
| POSNER BRIAN M (CFO) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Paid exercise price by delivering 70,833 shares
@ $0.42, valued at
$29.7k
|
|
09/25/2017 |
4
| Pionati Pellegrino (See Remarks) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Paid exercise price by delivering 69,978 shares
@ $0.42, valued at
$29.4k
|
|
07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/29/2017 |
4
| Johnson David Ian (President and CEO) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 300,000 shares
@ $0 |
|
06/28/2017 |
4
| Pionati Pellegrino (See Remarks) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 100,000 shares
@ $0 |
|
06/28/2017 |
4
| BARTON BRADFORD (COO) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 100,000 shares
@ $0 |
|
06/28/2017 |
4
| POSNER BRIAN M (CFO) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 100,000 shares
@ $0 |
|
06/26/2017 |
4
| Johnson David Ian (President and CEO) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 500,000 shares
@ $0 |
|
06/26/2017 |
4
| POSNER BRIAN M (CFO) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 205,715 shares
@ $0 |
|
06/26/2017 |
4
| Pionati Pellegrino (See Remarks) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 205,715 shares
@ $0 |
|
06/26/2017 |
4
| BARTON BRADFORD (COO) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 205,715 shares
@ $0 |
|
06/26/2017 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Acquired 100,000 shares
@ $0 |
|
06/21/2017 |
4
| Pionati Pellegrino (See Remarks) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Paid exercise price by delivering 10,032 shares
@ $0.37, valued at
$3.7k
|
|
04/13/2017 |
4
| CELGENE CORP /DE/ (10% Owner) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Acquired 296,277 shares
@ $0 |
|
04/04/2017 |
4
| WAGNER MARK T (Director) has filed a Form 4 on Alliqua BioMedical, Inc. |
04/04/2017 |
4
| BARTON BRADFORD (COO) has filed a Form 4 on Alliqua BioMedical, Inc. |
04/04/2017 |
4
| LEONE JOSEPH M (Director) has filed a Form 4 on Alliqua BioMedical, Inc. |
04/04/2017 |
4
| Pionati Pellegrino (See Remarks) has filed a Form 4 on Alliqua BioMedical, Inc. |
04/04/2017 |
4
| Johnson David Ian (President and CEO) has filed a Form 4 on Alliqua BioMedical, Inc. |
03/01/2017 |
4
| CELGENE CORP /DE/ (10% Owner) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Bought 4,000,000 shares
@ $0.5, valued at
$2M
|
|
03/01/2017 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on Alliqua BioMedical, Inc. |
05/20/2016 |
4
| WAGNER MARK T (Director) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Acquired 73,893 shares
@ $2.61, valued at
$192.9k
|
|
05/13/2016 |
4
| Johnson David Ian (President and CEO) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 300,000 shares
@ $0 |
|
|
|
|